We are live on ! Find out more
EOLS icon

Evolus

164 hedge funds and large institutions have $691M invested in Evolus in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 60 increasing their positions, 48 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 17

36% more capital invested

Capital invested by funds: $507M → $691M (+$184M)

25% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 48

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

12% more call options, than puts

Call options by funds: $8.41M | Put options by funds: $7.47M

9% more funds holding

Funds holding: 151164 (+13)

3.95% less ownership

Funds ownership: 84.21%80.26% (-3.9%)

Holders
164
Holders Change
+13
Holders Change %
+8.61%
% of All Funds
2.36%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.1%
New
31
Increased
60
Reduced
48
Closed
17
Calls
$8.41M
Puts
$7.47M
Net Calls
+$932K
Net Calls Change
-$7.83M
Name Holding Trade Value Shares
Change
Change in
Stake
CSS
26
Cubist Systematic Strategies
Connecticut
$4.48M +$1.27M +97,346 +44%
ZP
27
Zimmer Partners
New York
$4.2M +$3.9M +300,000 New
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$4.18M +$3.69M +283,962 +1,973%
DSCM
29
Divisadero Street Capital Management
Florida
$3.78M +$513K +39,462 +17%
Qube Research & Technologies (QRT)
30
Qube Research & Technologies (QRT)
United Kingdom
$3.75M +$2.88M +221,853 +481%
Voloridge Investment Management
31
Voloridge Investment Management
Florida
$3.67M +$3.41M +262,135 New
EIM
32
Essex Investment Management
Massachusetts
$3.57M +$48.9K +3,761 +1%
JP Morgan Chase
33
JP Morgan Chase
New York
$3.47M +$2.72M +209,183 +544%
TI
34
Trexquant Investment
Connecticut
$3.42M +$1.12M +85,954 +54%
Marshall Wace
35
Marshall Wace
United Kingdom
$3.06M -$4.36M -335,226 -61%
Walleye Capital
36
Walleye Capital
New York
$2.98M -$274K -21,062 -9%
Point72 Asset Management
37
Point72 Asset Management
Connecticut
$2.75M +$2.55M +196,200 New
Goldman Sachs
38
Goldman Sachs
New York
$2.61M +$623K +47,962 +35%
SCM
39
Soleus Capital Management
Connecticut
$2.24M +$2.08M +160,000 New
FCM
40
FourWorld Capital Management
New York
$2.15M -$650K -50,000 -25%
CM
41
CM Management
Florida
$2.1M
MIM
42
Monashee Investment Management
Massachusetts
$2.1M +$1.95M +150,000 New
Bank of New York Mellon
43
Bank of New York Mellon
New York
$2.03M -$218K -16,750 -10%
Stifel Financial
44
Stifel Financial
Missouri
$2.03M -$43.4K -3,340 -2%
Los Angeles Capital Management
45
Los Angeles Capital Management
California
$1.91M +$1.77M +136,226 New
Two Sigma Investments
46
Two Sigma Investments
New York
$1.86M +$81.8K +6,297 +5%
Wellington Management Group
47
Wellington Management Group
Massachusetts
$1.75M +$782K +60,168 +93%
Russell Investments Group
48
Russell Investments Group
United Kingdom
$1.56M
Charles Schwab
49
Charles Schwab
California
$1.55M -$53.2K -4,093 -4%
LCM
50
Legato Capital Management
California
$1.51M

EOLS Hedge Fund Activity: Q1 2024 in Review

164 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Evolus (EOLS) for Q1 2024, worth a combined $691M — up 36% from $507M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new EOLS positions and 17 closed out — a net gain of 14 holders — while 60 added to existing stakes and 48 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $23.3M. The largest seller was Stonepine Capital Management, cutting an estimated $34.6M.

  • 164 institutional investors held Evolus (EOLS) as of Q1 2024, up from 151 in Q4 2023.
  • Funds reported $691M of Evolus stock for Q1 2024, up 36% quarter-over-quarter.
  • 31 funds opened new Evolus positions in Q1 2024 and 17 closed out, a net change of +14 holders.
  • The largest Evolus buyer in Q1 2024 was Perceptive Advisors, an estimated $23.3M added.
  • The largest Evolus seller in Q1 2024 was Stonepine Capital Management, an estimated $34.6M sold.

Based on aggregated 13F filings for Q1 2024.